FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000UH2E7Q2

Market Closed - Deutsche Boerse AG 11:09:28 03/06/2024 pm IST
2.45 EUR +0.41% Intraday chart for FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
1 month-10.62%
3 months-47.97%
Date Price Change
03/24/03 2.45 +0.41%
31/24/31 2.44 -0.81%
30/24/30 2.46 -4.65%
29/24/29 2.58 +6.61%
28/24/28 2.42 -3.97%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 11:09 pm IST

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer UBS
WKN UH2E7Q
ISINDE000UH2E7Q2
Date issued 10/09/2021
Strike 52.24
Maturity Unlimited
Parity 5.32 : 1
Emission price 4.97
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 30.74
Lowest since issue 2.03
Spread 0.04
Spread %1.61%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.25 EUR
Average target price
39.97 EUR
Spread / Average Target
+1.84%
Consensus